Management of an older Marshall-Smith syndrome patient: a review of literature of MSS and craniosynostosis

Childs Nerv Syst. 2024 Aug;40(8):2609-2614. doi: 10.1007/s00381-024-06415-7. Epub 2024 Apr 22.

Abstract

Marshall-Smith Syndrome (MSS) is a rare progressive developmental disorder that severely impairs a patient's intellectual development and physical health. The only known cause for MSS is a mutation in the nuclear factor 1 X (NFIX) gene. This mutation affects neuronal development and protein transcription. Historically, most patients with MSS do not survive beyond 3 years of age. Reports of ocular findings are limited. We report a case of a 9-year-old MSS patient with progressive craniosynostosis, elevated intracranial pressure, and catastrophic ocular complications. A comprehensive PubMed literature search from 2018 to August 2022 updating a previous review of older literature produced 72 articles relating to MSS, which are reviewed.

Keywords: Craniosynostosis; Marshall-Smith syndrome; Mutation; NFIX.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Abnormalities, Multiple
  • Bone Diseases, Developmental
  • Child
  • Craniofacial Abnormalities
  • Craniosynostoses* / complications
  • Craniosynostoses* / genetics
  • Craniosynostoses* / surgery
  • Developmental Disabilities* / complications
  • Humans
  • Microcephaly / complications
  • Microcephaly / genetics
  • Septo-Optic Dysplasia / complications
  • Septo-Optic Dysplasia / genetics
  • Syndrome

Supplementary concepts

  • Marshall-Smith syndrome